GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veeva Systems Inc (FRA:VEE) » Definitions » ROE %

Veeva Systems (FRA:VEE) ROE %

: 12.87% (As of Jan. 2024)
View and export this data going back to 2013. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Veeva Systems's annualized net income for the quarter that ended in Jan. 2024 was €541 Mil. Veeva Systems's average Total Stockholders Equity over the quarter that ended in Jan. 2024 was €4,206 Mil. Therefore, Veeva Systems's annualized ROE % for the quarter that ended in Jan. 2024 was 12.87%.

The historical rank and industry rank for Veeva Systems's ROE % or its related term are showing as below:

FRA:VEE' s ROE % Range Over the Past 10 Years
Min: 11.76   Med: 15.62   Max: 21.44
Current: 12.61

During the past 13 years, Veeva Systems's highest ROE % was 21.44%. The lowest was 11.76%. And the median was 15.62%.

FRA:VEE's ROE % is ranked better than
73.64% of 607 companies
in the Healthcare Providers & Services industry
Industry Median: 4.07 vs FRA:VEE: 12.61

Veeva Systems ROE % Historical Data

The historical data trend for Veeva Systems's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veeva Systems Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.99 18.56 17.04 15.03 12.51

Veeva Systems Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.23 13.62 10.98 12.96 12.87

Competitive Comparison

For the Health Information Services subindustry, Veeva Systems's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veeva Systems ROE % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's ROE % distribution charts can be found below:

* The bar in red indicates where Veeva Systems's ROE % falls into.



Veeva Systems ROE % Calculation

Veeva Systems's annualized ROE % for the fiscal year that ended in Jan. 2024 is calculated as

ROE %=Net Income (A: Jan. 2024 )/( (Total Stockholders Equity (A: Jan. 2023 )+Total Stockholders Equity (A: Jan. 2024 ))/ count )
=482.597/( (3448.682+4263.948)/ 2 )
=482.597/3856.315
=12.51 %

Veeva Systems's annualized ROE % for the quarter that ended in Jan. 2024 is calculated as

ROE %=Net Income (Q: Jan. 2024 )/( (Total Stockholders Equity (Q: Oct. 2023 )+Total Stockholders Equity (Q: Jan. 2024 ))/ count )
=541.244/( (4147.645+4263.948)/ 2 )
=541.244/4205.7965
=12.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jan. 2024) net income data. ROE % is displayed in the 30-year financial page.


Veeva Systems  (FRA:VEE) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jan. 2024 )
=Net Income/Total Stockholders Equity
=541.244/4205.7965
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(541.244 / 2315.628)*(2315.628 / 5187.5155)*(5187.5155 / 4205.7965)
=Net Margin %*Asset Turnover*Equity Multiplier
=23.37 %*0.4464*1.2334
=ROA %*Equity Multiplier
=10.43 %*1.2334
=12.87 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jan. 2024 )
=Net Income/Total Stockholders Equity
=541.244/4205.7965
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (541.244 / 670.848) * (670.848 / 496.688) * (496.688 / 2315.628) * (2315.628 / 5187.5155) * (5187.5155 / 4205.7965)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8068 * 1.3506 * 21.45 % * 0.4464 * 1.2334
=12.87 %

Note: The net income data used here is four times the quarterly (Jan. 2024) net income data. The Revenue data used here is four times the quarterly (Jan. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Veeva Systems ROE % Related Terms

Thank you for viewing the detailed overview of Veeva Systems's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Veeva Systems (FRA:VEE) Business Description

Address
4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.

Veeva Systems (FRA:VEE) Headlines

No Headlines